The GEO Group Inc
GEO
CleanSpark
CLSK
Trump Media & Technology
DJT
Strategy
MSTR
Phunware
PHUN
US Stock MarketDetailed Quotes
NWBO Northwest Biotherapeutics
- 0.234000
- -0.005900-2.46%
15min DelayTrading Mar 19 14:12 ET
308.41MMarket Cap-3.90P/E (TTM)
0.248000High0.231000Low1.19MVolume0.244000Open0.239900Pre Close282.24KTurnover0.10%Turnover RatioLossP/E (Static)1.32BShares0.64890052wk High-3.84P/B282.46MFloat Cap0.21635052wk Low--Dividend TTM1.21BShs Float112.000000Historical High--Div YieldTTM7.09%Amplitude0.140000Historical Low0.236000Avg Price1Lot Size
Northwest Biotherapeutics Key Stats
EPS
According to the latest financial report of Northwest Biotherapeutics, the latest earnings per share (TTM) for the company is -0.02. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Northwest Biotherapeutics's free cash flow? The latest report shows it as -8.41M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Northwest Biotherapeutics shows that the company's current ratio is 0.09, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Northwest Biotherapeutics, the quick ratio is 0.05, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Northwest Biotherapeutics? The latest ROE figure is --, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Northwest Biotherapeutics, the total asset return on investment (ROA) is -67.79%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Northwest Biotherapeutics's latest financial report to see how their gross margin is doing - currently at 100.00%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Northwest Biotherapeutics, the net profit margin is -5.43K%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Trending Stocks
Donald Trump Donald Trump
Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump. Trump-Election Stocks refer to securities closely associated with business dealings, political actions, or events related to Donald Trump.